These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2389821)

  • 1. Sinefungin as treatment for American Leishmania in sensitive BALB/c and resistant C57BL/6 mice.
    Avila JL; Rojas T; Monzón H; Convit J
    Am J Trop Med Hyg; 1990 Aug; 43(2):139-45. PubMed ID: 2389821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Leishmania spp: formycin B treatment of cutaneous leishmaniasis in mice.
    Rojas T; Avila JL
    Parasitology; 1987 Jun; 94 ( Pt 3)():467-74. PubMed ID: 3614989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026.
    Neal RA; Croft SL; Nelson DJ
    Trans R Soc Trop Med Hyg; 1985; 79(1):122-8. PubMed ID: 3992630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of sinefungin susceptibility and drug-affinity for protein carboxymethyltransferase activity in American Leishmania species.
    Avila JL; Avila A
    Mol Biochem Parasitol; 1987 Nov; 26(1-2):69-75. PubMed ID: 3431568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3-alkylpyridine marine alkaloid analogues in Leishmania species related to American cutaneous leishmaniasis.
    Machado PA; Hilário FF; Carvalho LO; Silveira ML; Alves RB; Freitas RP; Coimbra ES
    Chem Biol Drug Des; 2012 Nov; 80(5):745-51. PubMed ID: 22882996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007).
    Khan MA; Maruno M; Khaskhely NM; Ramzi ST; Hosokawa A; Uezato H; Landires EA; Hashiguchi Y; Nonaka S
    Am J Trop Med Hyg; 2002 Aug; 67(2):184-90. PubMed ID: 12389945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sinefungin on growth and sterol composition of Leishmania promastigotes.
    Haughan PA; Chance ML; Goad LJ
    Exp Parasitol; 1993 Sep; 77(2):147-54. PubMed ID: 8375483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibitory effect of 3-deazaneplanocin A against several Leishmania mexicana and L. braziliensis strains.
    Avila JL; Avila A; Polegre MA; Marquez VE
    Am J Trop Med Hyg; 1997 Oct; 57(4):407-12. PubMed ID: 9347954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the major surface glycoprotein of Leishmania, gp63, in wild-type and sinefungin-resistant promastigotes.
    Soteriadou KP; Tzinia AK; Mamalaki A; Phelouzat MA; Lawrence F; Robert-Gero M
    Eur J Biochem; 1994 Jul; 223(1):61-8. PubMed ID: 8033909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory activity of sinefungin and SIBA (5'-deoxy-5'-S-isobutylthio-adenosine) on the growth of promastigotes and amastigotes of different species of Leishmania.
    Bachrach U; Schnur LF; El-On J; Greenblatt CL; Pearlman E; Robert-Gero M; Lederer E
    FEBS Lett; 1980 Dec; 121(2):287-91. PubMed ID: 6970144
    [No Abstract]   [Full Text] [Related]  

  • 13. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate.
    el-On J; Rubinstein N; Kernbaum S; Schnur LF
    Ann Trop Med Parasitol; 1986 Oct; 80(5):509-17. PubMed ID: 3632098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decanethiol functionalized silver nanoparticles are new powerful leishmanicidals in vitro.
    Isaac-Márquez AP; Talamás-Rohana P; Galindo-Sevilla N; Gaitan-Puch SE; Díaz-Díaz NA; Hernández-Ballina GA; Lezama-Dávila CM
    World J Microbiol Biotechnol; 2018 Feb; 34(3):38. PubMed ID: 29460068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
    Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
    ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of anti-cancer protein kinase inhibitors against Leishmania spp.
    Sanderson L; Yardley V; Croft SL
    J Antimicrob Chemother; 2014 Jul; 69(7):1888-91. PubMed ID: 24668412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.